Tag: Swedish Pharma

Mundipharma Australia to Commercialize Orexo’s Lead Product

Orexo AB, the fully integrated specialty pharmaceutical company addressing opioid addiction and pain, today announces the company has signed an agreement granting Mundipharma Pty Limited (Mundipharma ...

New Approach to Manufacture Therapeutic Peptides

Swedish Biomimetics 3000 Ltd (SB 3000), a UK-based company, has invented a new approach to manufacturing of therapeutic peptides that could replace traditional, large-scale batch manufacturing. The µL...

BioArctic Started Clinical Study for Parkinon’s Treatment

BioArctic AB announced that the first clinical study with ABBV-0805 has started in the U.S. AbbVie is responsible for the clinical development of ABBV-0805. The Phase 1 study in healthy volunteers wil...

Moberg Pharma and Bayer Entered into Agreement

Moberg Pharma AB has signed an exclusive license agreement with Bayer for commercialization of MOB-015 in Europe. Under the agreement, Moberg Pharma is eligible to receive up to EUR 50 million conting...

Swedish Company Received ODD for AIH Treatment

Calliditas Therapeutics AB today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the company for the treatment of Autoimmune hepatitis (AIH). A...

BioInvent’s Drug Got Orphan Designation

BioInvent International AB announces today that the U.S. Food and Drug Administration (FDA) has granted the Company orphan designation for its proprietary antibody BI-1206 for the treatment of mantle ...